| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/19/2004 | US20040033498 Diagnosing autoimmune diseases via variances in gene expression patterns in peripheral blood mononuclear cells |
| 02/19/2004 | US20040033496 Using electrically assisted nucleic acid hybridization and aluminum oxide solid support comprising immobilized nucleic acid probes and digoxigenin antibodies to detect target nucleotide sequences |
| 02/19/2004 | US20040033495 Determining cancerous state via detection of transcripts associated with neovascularization; anticarcinogenic/antitumor agents |
| 02/19/2004 | US20040033494 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/19/2004 | US20040033492 Using thin-film comprised of silicon nitride, rotating electric fields and translocation times to determine sequence of DNA sample |
| 02/19/2004 | US20040033491 Proteins and nucleic acids encoding same |
| 02/19/2004 | US20040033490 Epigenetic sequences for esophageal adenocarcinoma |
| 02/19/2004 | US20040033489 Establishment of biological cut-off values for predicting resistance to therapy |
| 02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |
| 02/19/2004 | US20040033485 Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data |
| 02/19/2004 | US20040033481 Preparing and designing antigrowth modulators which inhibit methionyl-tRNA synthetase activities in microscopic pathogens |
| 02/19/2004 | US20040033480 Use of resveratrol to regulate expression of apolipoprotein A1 |
| 02/19/2004 | US20040033230 Breast tumor polypeptides, polynucleotides that encode them, antigen presenting cells that express them, and T cells that are specific for cells that express them. |
| 02/19/2004 | US20040033229 PSMA antibodies and protein multimers |
| 02/19/2004 | US20040031698 Analysis apparatus comprising dielectric plates, electrodes, immobilized enzymes and transducers, used for microfluidic assaying with consistency and accuracy |
| 02/19/2004 | US20040031682 Sampling blood glucose using detectors having coatings comprising enzymes, cofactors, oxidizers and/or reducing agents; microfluidics |
| 02/19/2004 | DE10237073A1 Determining genetic disposition to thrombosis, by testing for presence of at least two allelic polymorphisms associated with increased risk, followed by multifactorial analysis of the results |
| 02/19/2004 | DE10236529A1 Method for identifying modulators of 4-hydroxyphenylpyruvate dioxygenase, useful potentially as herbicides, by fluorescent polarization detection of interaction, also new modulators |
| 02/19/2004 | DE10236329A1 Detecting activity of protein-tyrosine phosphatase by detecting hydrolysis of 6,8-difluoro-4-methylumbelliferyl phosphate, useful for identifying modulators of the enzyme that can be used to treat diabetes |
| 02/19/2004 | DE10236034A1 New labeling material, useful in marking products for protection against counterfeiting, comprises nucleic acid encapsulated in soluble or meltable packaging |
| 02/19/2004 | DE10235129A1 Identifying fungicides that inhibit ribose-5-phosphate isomerase, useful for plant protection |
| 02/19/2004 | DE10234570A1 New DNA fragment encoding mutant O6-antigen polymerase, useful for identifying Escherichia coli DSM 6601 and for attenuating other O6 serotype strains |
| 02/19/2004 | DE10233346A1 Nutrient medium for detecting microbes in presence of hydrogen peroxide, useful for checking efficiency of fumigation, contains sulfur-containing salts for neutralizing peroxide |
| 02/19/2004 | DE10219373A1 Diagnostic kit, useful for assessing a subject's tolerance of drugs, comprises reagents for determining alleles of genes encoding detoxification enzymes |
| 02/19/2004 | DE10212570B4 Amperometrischer Dickschicht-Biosensor zur Bestimmung der Wasserstoffperoxid-Konzentration in einer Lösung und Verfahren zur Herstellung des Sensors Amperometric thick-film biosensor for the determination of hydrogen peroxide concentration in a solution and method for manufacturing the sensor |
| 02/19/2004 | CA2818693A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2759572A1 Isolation and identification of t cells |
| 02/19/2004 | CA2502720A1 Method and device for identifying micro organisms |
| 02/19/2004 | CA2495935A1 Screening strategy for anticancer drugs |
| 02/19/2004 | CA2495520A1 Apparatus and methods for detecting dna in biological samples |
| 02/19/2004 | CA2495085A1 Diagnosis and treatment of tuberous sclerosis |
| 02/19/2004 | CA2494930A1 Modified forms of interfering rna molecules |
| 02/19/2004 | CA2494928A1 Cancer diagnostics and prognostics |
| 02/19/2004 | CA2494908A1 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 02/19/2004 | CA2494844A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2494720A1 Nucleic acid detection methods using universal priming |
| 02/19/2004 | CA2494585A1 Methods for the treatment of dementia based on apo e genotype |
| 02/19/2004 | CA2494422A1 Method for diagnosing multiple sclerosis |
| 02/19/2004 | CA2494252A1 Psmcs as modifiers of the rb pathway and methods of use |
| 02/19/2004 | CA2494236A1 Csnk1gs as modifiers of the p21 pathway and methods of use |
| 02/19/2004 | CA2494182A1 Interpretation model for the uv-vis spectra of microorganisms |
| 02/19/2004 | CA2493716A1 Uncoupling of dna propagation and expression of protein for phage display |
| 02/19/2004 | CA2493297A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 02/19/2004 | CA2427693A1 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof |
| 02/18/2004 | EP1389638A1 Improved fluorescent resonance energy transfer probes |
| 02/18/2004 | EP1389637A1 Novel forms of interfering RNA molecules |
| 02/18/2004 | EP1389463A1 Medicine for inhibiting drug elimination pump |
| 02/18/2004 | EP1389306A2 Method for detecting progredient chronic dementia, and corresponding peptides and detection reagents |
| 02/18/2004 | EP1389305A2 Peptide fragmentation |
| 02/18/2004 | EP1389304A1 Adherent entities and uses therefor |
| 02/18/2004 | EP1389242A2 Detecting microorganisms of the yersinia pestis/yersinia pseudotuberculosis species and/or differentiating between yersinia pestis and yersinia pseudotuberculosis |
| 02/18/2004 | EP1389241A2 Polynucleotide sequencing method |
| 02/18/2004 | EP1389240A2 Mdr1 variants and methods for their use |
| 02/18/2004 | EP1389238A2 Regulation of human prostaglandin-f synthase 1-like protein |
| 02/18/2004 | EP1389235A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/18/2004 | EP1389129A1 Methods of treating respiratory conditions |
| 02/18/2004 | EP1389110A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 02/18/2004 | EP1237408B1 Pour-on formulations |
| 02/18/2004 | EP1218105B1 Structured reaction substrate |
| 02/18/2004 | EP1137804B1 Method for detecting in vitro a target substance in a sample comprising the labelling of said substance with a reporter gene and the sequences required for expressing said reporter gene in vitro |
| 02/18/2004 | EP1137801B1 Diagnostic method based on the function of a protein produced in a cell-free environement from a nucleic acid sample |
| 02/18/2004 | EP0734264B1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/2004 | CN1476537A Diagnostic agents for prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing same |
| 02/18/2004 | CN1476536A System for electro physiological measurements |
| 02/18/2004 | CN1476485A Reagent box used for detecting non pathogenic or pathogenic A type influenze virus H5 subtype virus |
| 02/18/2004 | CN1476481A Isolated luciferases and use thereof |
| 02/18/2004 | CN1476478A Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/18/2004 | CN1475806A Magnetic tunnel junction biochip carrier and chip using said carrier and its manufacturing method and method of proceeding detection against biomolecule |
| 02/18/2004 | CN1475579A Primer and probe for rat lymphocyle CD4 gene quantitatire expression and testing |
| 02/18/2004 | CN1475578A Preparation method of new gene chip solid phase carrier |
| 02/18/2004 | CN1475576A Single chain DNA fast preparation technology and reagent box |
| 02/18/2004 | CN1475106A Method of quickly improving paddy rice quality |
| 02/18/2004 | CN1138862C Collector for nucleic acid analysis and application method |
| 02/18/2004 | CN1138859C Infection clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 02/18/2004 | CN1138855C Method for monitoring bio-activity in fluids |
| 02/17/2004 | US6692975 Compounds for use in the detection of preferential particles in sample |
| 02/17/2004 | US6692973 Surface binding of an immunoglobulin to a flexible polymer using a water soluble varnish matrix |
| 02/17/2004 | US6692969 Diagnosis of chronic fatigue syndrome or fibromyalgia; using quantitative fibrinogen, prothrombin fragment 1+2, thrombin/ antithrombin complexes and soluble fibrin monomer blood tests |
| 02/17/2004 | US6692965 Exposing to molecular beacon comprised of nucleotides complementary to rna of interest; isolating cells that fluoresce upon hybridization |
| 02/17/2004 | US6692957 Isolation of preferential aggregates in sample; obtain aggregates, transform, isolate aggregates expressing green fluorescent protein |
| 02/17/2004 | US6692948 Isolated human kinase proteins |
| 02/17/2004 | US6692943 Persephin and related growth factors |
| 02/17/2004 | US6692938 Peptide for use in the treatment of inflammation, arthritis, glomerulonephritis, asthma, psoriasis, viral infections, cancer, atherosclerosis, leukemia and autoimmune diseases |
| 02/17/2004 | US6692937 Nucleotide sequences coding membrane protein for use in the treatment of cancer, infection and heart defects |
| 02/17/2004 | US6692932 Thermostable DNA polymerase from anaerocellum thermophilum |
| 02/17/2004 | US6692930 Immunoglobulin for use in the detection of preferential meats; for use in accurately labeling meats |
| 02/17/2004 | US6692929 Polypeptide; for use in detection of cell cycle modulators |
| 02/17/2004 | US6692928 Methods for identifying cardiovascular agents |
| 02/17/2004 | US6692920 Antibody which specifically binds to a polypeptide comprising a naturally occurring ammo acid sequence of a novel expressed chemokine (adec) from inflamed adenoid tissue |
| 02/17/2004 | US6692918 Amplification of prferential nucleotide sequences; obtain nucleotide sequences, denature, incubate with primer and polymerase, amplify, recover nucleotide sequences |
| 02/17/2004 | US6692917 Systems and methods for invasive cleavage reaction on dendrimers |
| 02/17/2004 | US6692915 A hairpin primer interrogates the composite subsequences in a two-step process resulting first in a polymerase extended product whose synthesis identifies the first subsequence of the composite subsequence |
| 02/17/2004 | US6692913 Using a reporter gene after gene transfer in eukaryotic cells in the same culture vessel, |
| 02/17/2004 | US6692909 Coding sequence polymorphisms in vascular pathology genes |
| 02/17/2004 | US6692908 Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor |
| 02/17/2004 | US6692907 Conserved motif of hepatitis C virus E2/NS1 region |
| 02/17/2004 | US6692751 Methods and systems for producing recombinant viral antigens |
| 02/17/2004 | US6692744 Betaglycan as an inhibin receptor and uses thereof |
| 02/17/2004 | CA2224034C Mediators useful in an electrochemical biosensor |
| 02/17/2004 | CA2152410C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof |